Clinical Trials Logo

Filter by:
NCT ID: NCT05331716 Completed - Clinical trials for Ventricular Tachycardia

Modification of the Local Abnormal Ventricular Activity Only

LAVAONLY
Start date: January 1, 2019
Phase:
Study type: Observational

Local abnormal ventricular activity (LAVA) is composed of high-frequency, mainly low voltage signals that represent near-field signals from slow-conducting tissue and thus potential VT isthmuses. The identification of LAVA potentials and their modification have usually been a complimentary component of the substrate-based modification of scar related ventricular arrhtyhmias. With better identification through technical solutions and improved algorithms, LAVA modification may be feasible for treatment in therapy refractory VT.

NCT ID: NCT05327595 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of LY3549492 in Participants With Type 2 Diabetes Mellitus (T2DM)

Start date: May 9, 2022
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to evaluate the safety and tolerability of LY3549492 in participants with T2DM. Blood tests will be done to check how much LY3549492 gets into the bloodstream and how the body handles LY3549492. This study has two parts. Each participant will enroll in only one part. The study will last either 12 or 13 weeks, depending on part.

NCT ID: NCT05326178 Completed - Depressive Disorder Clinical Trials

Evaluation of a Website to Improve Depression Literacy in Parents of Healthy Adolescents

Start date: January 12, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy and acceptability of the website "ich bin alles" (https://www.ich-bin-alles.de/) to improve depression literacy (knowledge about depression, which aid the recognition, treatment or prevention of depression) in parents of healthy adolescents without a mental health condition. The investigators will examine whether the website improves depression literacy in parents of adolescents aged 12 to 18 years without a mental health condition. The investigators will also assess the acceptability of the website among the participants.

NCT ID: NCT05325268 Completed - Clinical trials for Monteggia's Fracture

Monteggia Fractures: Analysis of Patient Reported Outcome Measurements in Correlation to Ulnar Fracture Localization

Start date: June 1, 2018
Phase:
Study type: Observational

Patients who had suffered a Monteggia fracture (lesion of the elbow) will be assessed regarding clinical and functional outcome (PROM) after treatment with osteosynthesis.

NCT ID: NCT05322473 Completed - Clinical trials for Hidradenitis Suppurativa

Evaluation of Sonelokimab for the Treatment of Patients With Active Moderate to Severe Hidradenitis Suppurativa

Start date: April 25, 2022
Phase: Phase 2
Study type: Interventional

This is a study to demonstrate the clinical efficacy and safety of the nanobody® sonelokimab administered subcutaneously (sc) compared with placebo in the treatment of adult participants with moderate to severe hidradenitis suppurativa.

NCT ID: NCT05322109 Completed - Clinical trials for Heart Failure, Diastolic

Cardiac Magnetic Resonance Tomography for Heart Failure With Preserved Ejection Fraction

Start date: April 23, 2021
Phase:
Study type: Observational

The diagnosis of heart failure with preserved ejection fraction has so far been made primarily according to criteria determined by echocardiography, or invasively by measuring the left ventricular filling pressures. Increasingly, CMR is also evaluated with regard to the diagnosis of cardiac insufficiency with preserved pump function.However, it is still unclear which parameters can be used meaningfully for diagnostics.To answer this question, the investigators want to retrospectively evaluate data collected from patients with a clinical indication for CMR and coronary angiography.

NCT ID: NCT05320991 Completed - Social Cognition Clinical Trials

Effects of Ketamine on Mentalizing and Metacognition in Healthy Volunteers

METAKETAII
Start date: June 15, 2019
Phase: Phase 4
Study type: Interventional

Antipsychotic medication shows generally good effect sizes when looking at reduction of positive psychotic symptoms of schizophrenia, such as paranoia or delusion. However, social functioning often remains deficient in patients, meaning dopamine-receptor antagonists are not sufficient in treatment of people with schizophrenia. A naturalistic video-based paradigm, named MASC has been used in the past to model over- and undermentalizing in patients with autism spectrum disorder and schizophrenia, since deficits in mentalizing can be explained by either overinterpreting a social situation (e.g. paranoid thoughts about intentions of others towards self) or by lacking the skill to read intentions of others. To find out whether experimental manipulation via a non-competetive N-methyl-D-aspartate antagonist can induce difficulties with social cognition similar to those observed in people with schizophrenia, the investigators will conduct a RCT applying either ketamine or a placebo intravenously while participants are completing the above mentioned mentalizing task in the fMRI-scanner.

NCT ID: NCT05319925 Completed - Cancer Clinical Trials

Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany

FIAT
Start date: June 1, 2022
Phase:
Study type: Observational

This study aims to develop and to validate a standardised German-language instrument for measuring experienced financial effects of a cancer diagnosis and therapy in a cross-sectional bi-centre study. Obtained data will make the patient-related description of financial difficulties more comprehensible, communicable and addressable in the future, e.g. by offering targeted advisory aids or considering financial effects in health technology assessments.

NCT ID: NCT05318248 Completed - Stress Clinical Trials

The Role of Stress Neuromodulators in Decision Making Under Risk (Part II)

SID2
Start date: March 1, 2022
Phase: N/A
Study type: Interventional

The aim of the proposed project is to combine precise pharmacological manipulation of the noradrenergic system with behavioral modeling of memory processes, and fMRI methods to study the effect of a pharmacologically induced blockade of the noradrenergic system on memory processes. Behaviorally, the investigators will focus on the effect of the noradrenergic blockade on working memory performance, and recognition memory.

NCT ID: NCT05317143 Completed - Prostate Cancer Clinical Trials

Evaluation of Prostate Cancer Margins

Start date: February 22, 2022
Phase:
Study type: Observational

Pathological assessment of prostate tissue